Gainers
- MorphoSys (NASDAQ:MOR) stock rose 22.1% to $5.57 during Tuesday's after-market session. Trading volume for this security closed at 969.9K, accounting for 2119.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $760.8 million.
- Spero Therapeutics (NASDAQ:SPRO) stock rose 13.81% to $1.1. The company's market cap stands at $36.1 million.
- Rhythm Pharmaceuticals (NASDAQ:RYTM) stock rose 11.07% to $3.71. The company's market cap stands at $186.9 million.
- Enochian BioSciences (NASDAQ:ENOB) stock rose 8.9% to $3.79. The market value of their outstanding shares is at $200.6 million.
- Verrica Pharmaceuticals (NASDAQ:VRCA) stock increased by 8.57% to $2.28. The market value of their outstanding shares is at $62.7 million.
- AcelRx Pharmaceuticals (NASDAQ:ACRX) shares moved upwards by 8.32% to $0.21. The market value of their outstanding shares is at $31.4 million.
Losers
- 180 Life Sciences (NASDAQ:ATNF) stock fell 39.6% to $0.81 during Tuesday's after-market session. This security traded at a volume of 316.9K shares come close, making up 71.8% of its average volume over the last 100 days. The company's market cap stands at $27.6 million.
- Belite Bio (NASDAQ:BLTE) shares decreased by 11.07% to $25.08. The market value of their outstanding shares is at $604.3 million.
- Cosmos Holdings (NASDAQ:COSM) stock decreased by 10.58% to $0.63. Today's trading volume for this security ended up closing at 149.6K shares, which is 16.7 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $11.7 million.
- Geovax Labs (NASDAQ:GOVX) shares declined by 9.16% to $1.29. This security traded at a volume of 361.3K shares come close, making up 3.9% of its average volume over the last 100 days. The market value of their outstanding shares is at $13.6 million.
- Viking Therapeutics (NASDAQ:VKTX) shares fell 7.49% to $2.1. The company's market cap stands at $162.4 million.
- BioLine Rx (NASDAQ:BLRX) stock declined by 6.07% to $1.24. The company's market cap stands at $59.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
